Details of the Drug

General Information of Drug (ID: DMDRJ31)

Drug Name
Antibodie derivative 9
Synonyms PMID28621580-Compound-WO2016044219
Indication
Disease Entry ICD 11 Status REF
Carotid artery disease 8B10 Patented [1]
Corneal neovascularization 9A78 Patented [1]
Macular degeneration 9B78.3 Patented [1]
Solid tumour/cancer 2A00-2F9Z Patented [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
D0WL5P
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Vascular endothelial growth factor A (VEGFA) TTOHSBA VEGFA_HUMAN Stablizer [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Carotid artery disease
ICD Disease Classification 8B10
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Vascular endothelial growth factor A (VEGFA) DTT VEGFA 3.61E-01 0.15 0.47
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Sep;27(9):987-1004.